Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
King Of Prussia, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Phio Pharmaceuticals Corp. has filed 870 SEC EDGAR filings since 25 Oct 2011

SEC filing history

Showing 151-175 of 870 matching filings.

Per page
25
Current page
7
10-Q File 001-36304

FORM 10-Q FOR 3/31/24

Filing date
09 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
DEFA14A File 001-36304

FORM DEFA14A

Filing date
08 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36304

DEFINITIVE PROXY STATEMENT

Filing date
08 May 2024
Reporting date
17 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-36304

ANNUAL REPORT TO SECURITY HOLDERS

Filing date
08 May 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-36304

PRELIMINARY PROXY STATEMENT

Filing date
22 Apr 2024
Reporting date
17 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36304

CURRENT REPORT

Filing date
02 Apr 2024
Reporting date
02 Apr 2024
Next action
Verify source filing
10-K File 001-36304

10-K FOR 12/31/23

Filing date
01 Apr 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
4

4 filing

Filing date
05 Mar 2024
Reporting date
01 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Feb 2024
Reporting date
26 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Feb 2024
Reporting date
20 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Feb 2024
Reporting date
15 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86901

AMENDMENT NO. 4 TO SCHEDULE 13G

Filing date
06 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-276146

424B3

Filing date
28 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-276146

EFFECT filing

Filing date
27 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
22 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
21 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-276146

REGISTRATION STATEMENT

Filing date
19 Dec 2023
Reporting date
Not listed
Next action
Verify source filing
D File 021-500104

D filing

Filing date
19 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36304

CURRENT REPORT

Filing date
08 Dec 2023
Reporting date
06 Dec 2023
Next action
Verify source filing
8-K File 001-36304

CURRENT REPORT

Filing date
09 Nov 2023
Reporting date
09 Nov 2023
Next action
Verify source filing
10-Q File 001-36304

FORM 10-Q FOR SEPT 2023

Filing date
09 Nov 2023
Reporting date
30 Sep 2023
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Oct 2023
Reporting date
01 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-274787

FORM S-8

Filing date
29 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .